Aquarius PopulationHealth
Transforming health, for everyone
The results of our economic evaluation comparing the use of mRNA and DNA assays in screening for cervical cancer in England were published in BMJ Open and are now available online. Results show large cost savings from avoiding unnecessary testing and follow-up, which can benefit women and healthcare services.
Continue reading
Dr Elisabeth Adams, Managing Director of Aquarius Population Health, presented on opportunities for rapid tests in influenza and HPV at international conferences in June.
This has been a busy week for the Aquarius Population Health team. We had two posters at the Society for Medical Decision Making in London (12-15th June), which Elisabeth presented. The posters showcased results from two studies we have done looking at the impact of implementing a rapid near-patient test for influenza and RSV. This was a collaborative project with Enigma Diagnostics and Guy’s and St Thomas’ NHS Trust. Results indicated that a rapid test could improve clinical management of patients with influenza, and could save commissioners money. It also illustrated how a rapid test could prevent unnecessary isolation bed days compared to current practice (presumptive isolation while waiting for results of the standard laboratory test results for influenza).
Our managing director, Dr Elisabeth Adams, is presenting two posters at the 30th annual International Papillomavirus Conference in Lisbon, Portugal. The first poster, “Exploring the value of a rapid, on-demand test for the detection of human papillomavirus”, is a detailed look at the current patient pathways for cervical screening programmes, and key opinion leaders’ views on the impact a rapid diagnostic would have on the health and overall wellbeing of women.